We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
This article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleDisclosure: The authors of this article and owners of Next Investors, S3 Consortium Pty Ltd, and ass...
Read ArticleHe’s baaack! Fresh from founding and listing immune-oncology play Chimeric, Paul Hopper can add Radi...
Read ArticleSUDA Pharmaceuticals (SUD) has its lead product for short-term insomnia, ZolpiMist, approved by the...
Read ArticleLast week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sal...
Read ArticleRetail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired f...
Read ArticleThe Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused dr...
Read Article03 Sep 2021 - Suda Pharmaceuticals (ASX: SUD) has appointed Dr John Maher to its scientific advisory...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleVirginia is the latest US state to legalise marijuana and they’re celebrating with the first annual...
Read ArticleIt was another positive close for the Australian bourse today with energy the standout sector. The A...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleMassachusetts based cannabis operator MariMed has just announced a joint collaboration with the lege...
Read ArticleThe ASX200 health stocks index (XHJ) fell by 0.14% this morning, compared to the broader index which...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleThe new appointee’s responsibilities include technology transfer, manufacturing, and quality aspects...
Read ArticleThe biggest winner in health stocks today was Hydrix (ASX:HYD) – up 9.68% off the back of news that...
Read ArticleThe Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The...
Read ArticleThe biotechnology company released its fourth-quarter report, unveiling cash receipts for the quarte...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleAfter starting the day in negative territory, the Australian bourse recovered to finish higher. The...
Read ArticleThis week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannab...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleCannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Me...
Read ArticleEach week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength In...
Read ArticleConnecticut has become the latest US state to legalise recreational use of marijuana. The state’s go...
Read ArticleEach week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength In...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticlePlenty of action on the biotech front today has provided ASX investors with some mouth-watering gain...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleSUDA Pharmaceuticals (ASX:SUD) has announced it has signed a global, exclusive agreement wit...
Read ArticleIt was an ugly day on Australia’s bourse following the plunge on Wall Street on Friday. The ASX 200...
Read ArticleThe US cannabis sector received a big lift after Amazon announced that job applicants at its offices...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleThere was plenty of action in the US regulatory front within the cannabis sector this week. A couple...
Read ArticleIt was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies relea...
Read ArticleIn 2021, which of Europe and North America is the place to be for ASX cannabis stocks? The case fo...
Read ArticleA cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first ti...
Read ArticleApril 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually l...
Read ArticleThe number of medical cannabis prescriptions issued under Australia’s special access scheme just kee...
Read ArticleAustralia’s medical marijuana industry is showing strong growth, according to an industry-leading bi...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticlePot legalisation is creeping across the US state by state, and a major market could be about to join...
Read ArticleSummary SUDA Pharmaceuticals Limited (ASX:SUD) is anticipated to make significant progress in it...
Read ArticleSummary SUDA Pharmaceuticals Limited (ASX:SUD) has raised A$2.7 million via successful completio...
Read ArticleSummary SUDA Pharmaceuticals (ASX:SUD) has obtained firm commitments for a A$2.76 million capita...
Read ArticleSUDA Pharmaceuticals (ASX:SUD), a company focussed on oromucosal drug delivery, has announce...
Read ArticleSummary SUDA Pharmaceuticals Limited (ASX:SUD) has recently released its Annual General Meeting...
Read ArticleSummary SUDA Pharmaceuticals (ASX:SUD) is a leading oro-mucosal drug delivery leader based in Au...
Read ArticleThe receipt of $662,000 in additional funding will further support SUDA’s development work for the c...
Read ArticleSummary SUDA Pharmaceuticals Ltd (ASX:SUD) recently released its quarterly activities report for...
Read ArticleSummary SUDA Pharmaceuticals (ASX:SUD) has recently published its October 2020 newsletter for sha...
Read ArticleASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe capital raising wave shows no sign of crashing with August’s total coming in at $4.7bn. Once aga...
Read ArticleA quick wrap of the ASX’s key winners and losers on Monday, August 31. Data is taken after the marke...
Read ArticleAs pot-stock aficionados know, investing in cannabis means navigating a labyrinth of regulatory deve...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleA quick wrap of the ASX’s key winners and losers on Thursday, July 30. Data is taken after the marke...
Read ArticlePerth-based SUDA Pharmaceuticals (ASX:SUD) has announced the TGA has approved its lead produ...
Read ArticleSUDA Pharmaceuticals Limited (ASX:SUD) soared above 150 per cent to $0.068 on ASX on 29 July 2020, f...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, July 29. Data is taken after the mark...
Read ArticleThe Suda Pharmaceuticals Ltd (ASX: SUD) share price has soared 207.4% today, at the time of writing...
Read ArticlePerth-based SUDA Pharmaceuticals (ASX: SUD) has received approval from the Therapeutics Goods Admini...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSUDA Pharmaceuticals Limited (ASX:SUD), the global leader in reformulating and delivering medication...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleSuda’s lead product ZolpiMist is the oro-mucosal spray version of the blockbuster insomnia drug Ambi...
Read ArticleAustralia’s oro-mucosal drug delivery leader, SUDA Pharmaceuticals Limited (ASX:SUD) has recently an...
Read ArticleThe Japanese Patent Office has accepted Anagrelide cancer patent application, and the patent would n...
Read ArticleSUDA Pharmaceuticals Limited (ASX:SUD), an Australia-based oro-mucosal drug delivery player, notifie...
Read ArticleASX shares can help you build a diversified dividend portfolio. In this coronavirus era, finding th...
Read ArticleOro-mucosal drug delivery company, SUDA Pharmaceuticals Limited (ASX:SUD) has announced another set...
Read ArticleThe company develops oral sprays using its OroMist® technology to reformulate existing pharmaceutica...
Read ArticleIn a recent letter to its top shareholders, Perth-based oro-mucosal drug delivery company SUDA Pharm...
Read ArticleThe company recently entered into an exclusive licence agreement with South Korean subsidiary of Mit...
Read ArticleZelira Therapeutics (ASX:ZLD) chief Dr Richard Hopkins confirms what your columnist suspected was a...
Read ArticleProgressing remarkably with the commercialisation of its insomnia drug ZolpiMistTM, the oro-mucosal...
Read ArticleStockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and pickin...
Read ArticleContinuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA...
Read ArticleContinuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA...
Read ArticleContinuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA...
Read ArticleFew people are at their desks in the week between Christmas and new year, which means it’s a prime d...
Read ArticleViagra mouth spray maker SUDA Pharmaceuticals (ASX:SUD) has talked a multi-billion dollar pharmaceut...
Read ArticleSUDA Pharmaceuticals (ASX:SUD) has entered into a fully-funded, feasibility study and option...
Read ArticleA novel product for the consumer paediatric market could soon be developed after drug delivery speci...
Read ArticleNew Zealand’s medicines regulator has recommended the country fall in line with Australia’s new code...
Read ArticleSUDA Pharmaceuticals (ASX:SUD), a company focused on oro-mucosal drug delivery, has announce...
Read ArticleFor a certain generation of investors the word ‘laser’ is indelibly tied to a Dr Evil reference. Ove...
Read ArticleThailand has not yet legalised marijuana but pretty soon Thais will not only be able to grow their o...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleJames Dean is returning to the silver screens after a six and a half decade absence. The Rebel Witho...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleDrug delivery specialist SUDA Pharmaceuticals (ASX: SUD) has finalised a deal with medical cannabis...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleBased in the United States and Australia, SUDA Pharmaceuticals Ltd (ASX: SUD) is a leading drug deli...
Read ArticleOro-mucosal drug delivery giant, SUDA Pharmaceuticals Limited (ASX: SUD) is engaged in the pharmaceu...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleKicking back at your favourite cafe and smoking a joint is an activity historically associated with...
Read ArticleOn Stockhead today: Tim Treadgold on why gold miner Pantoro is a stock to watch, milk stocks in heal...
Read ArticleAustralian-headquartered global pharmaceutical leader, SUDA Pharmaceuticals Limited (ASX: SUD) is en...
Read ArticleSUDA Pharmaceuticals (ASX SUD), a company focused on oro-mucosal drug delivery, has announce...
Read ArticleThe notion of ‘everything old is new again’ applies not just to fickle fashion trends, but to drug d...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleDrugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking m...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleSUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the life...
Read ArticleOn Stockhead today, what small fries can learn from big health caps, an expert’s view of where crypt...
Read ArticleSUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery company headquartered in Perth, fo...
Read ArticleImugene Limited (ASX: IMU), an Australian-headquartered clinical-stage immuno-oncology company, focu...
Read ArticleOn Stockhead today, will cobalt prices surge after another big mine gets mothballed, the tech and po...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleTo increase the bioavailability of administered medications, Australian-headquartered SUDA Pharmaceu...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe federal government has taken steps to cut red tape and speed up the granting of licences for Aus...
Read ArticleOn Stockhead today – mining lithium from seawater, our monthly dairy stocks update, and why Hot Copp...
Read ArticleSUDA Pharmaceuticals Ltd (ASX: SUD) is an oro-mucosal drug delivery company that is reformulating me...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOn 31 July 2019, SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery firm, has release...
Read ArticleAn oro-mucosal drug delivery company headquartered in Perth, SUDA Pharmaceuticals Ltd (ASX: SUD) use...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleWith the rise in cases of the deadly disease cancer creating havoc across the globe, it is the need...
Read ArticleBiotech company Patrys Limited (ASX:PAB) shares got a bump this morning, after some more positive an...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe Queensland government has formally awarded Authority to Prospect to coal seam gas explorer Armou...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleWth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleGlobally, the cannabis market is estimated to be valued at around USD 150 billion. According to the...
Read ArticleThis week the US state of Illinois became the first to pass a bill allowing retail sales of recreati...
Read ArticleAt the start of every trading day, it can be useful to know which stocks are humming out of the gate...
Read ArticleAustralian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Featur...
Read ArticleAustralian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Featur...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
